IP Library › Granted Patent US 11,826,280
Granted Patent B2
US 11,826,280 · App. 17/265,648 · Granted Nov 28, 2023

Lacrimal canalicular delivery system and methods of use

Inventors: Bradley P. Barnett (Apex, NC); Albert S. Jun (Towson, MD)
Assignee: The Johns Hopkins University
A61F9/0017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,826,280
App. No.
17/265,648
Granted
Nov 28, 2023
Kind
B2
Abstract

Lacrimal canalicular delivery systems (LCDS) and their methods of use for the delivery of implants at a specific location into the canaliculus of a subject generally include a lumen, a guide wire, and an implant. The guide wire and implant are within the lumen. When pressure is applied to the guide wire, the guide wire pushes the implant out of the lumen into a specific location into the canaliculus of a subject.

Claims (18)

1. A lacrimal canalicular delivery system comprising:

a sheath;

a catheter movably disposed within the sheath;

an eyelid alignment platform;

a handle connected to the catheter; and

a spring wherein the spring is disposed between the sheath and the catheter and wherein the spring is distally attached to a portion of the handle that is contiguous with the eyelid alignment platform and wherein a proximal portion of the spring is attached to a proximal element of the catheter.

2. The lacrimal canalicular delivery system of claim 1 wherein the catheter is open when the spring is maximally compressed.

3. The lacrimal canalicular delivery system of claim 1 wherein the catheter is retracted when the spring is maximally expanded.

4. The lacrimal canalicular delivery system of claim 1 wherein the catheter defines a lumen and wherein an implant is disposed within the lumen.

5. The lacrimal canalicular delivery system of claim 4 wherein the implant is selected from the group consisting of a canalicular occlusive device, an endoluminal device, depot drug, drug, an electric stimulation device, and a combination thereof.

6. A method of delivering an implant to a canaliculus of a subject comprising the steps of:

providing a lacrimal canalicular delivery system of claim 4 ;

aligning the eyelid alignment platform on an eyelid of a subject over the puntal os; and

administering the implant into the canaliculus of a subject by applying force to the catheter.

7. The method of delivering an implant of claim 6 wherein the implant is selected from the group consisting of a canalicular occlusive device, an endoluminal device, an electric stimulation device, a depot drug delivery device, a drug and a combination thereof.

8. The method of delivering an implant of claim 6 wherein the catheter extends through a punctal os into the canaliculus of the subject and the implant is released into the canaliculus when the catheter is retracted.

9. The method of claim 8 wherein the implant delivers a pharmaceutical agent and wherein the implant is released close to the punctal os so that the pharmaceutical agent elutes in tears of the subject.

10. The method of claim 8 wherein the implant delivers a pharmaceutical agent and wherein the implant is released deep in the canaliculus so that the pharmaceutical agent is prevented from eluting in the tears.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2021
From: BARNETT, BRADLEY P.; JUN, ALBERT S.
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 055317/0436 →
Continuity (2)
Provisional Application 62714219 · Aug 3, 2018
Related Publication 20210298950A1 · Sep 30, 2021
Cited By (1)
US 12,678,276